Literature DB >> 10747125

Fractionation of membrane components from tachyzoite forms of Toxoplasma gondii: differential recognition by immunoglobulin M (IgM) and IgG present in sera from patients with acute or chronic toxoplasmosis.

M Giraldo1, H Cannizzaro, M A Ferguson, I C Almeida, R T Gazzinelli.   

Abstract

Tachyzoite forms of Toxoplasma gondii were subjected to a sequential organic solvent extraction, which allows fractionation of membrane components according to their degrees of hydrophobicity, yielding three fractions named F1 (most hydrophobic) to F3 (least hydrophobic). Fractions F2 (80.85% specificity and 86.95% sensitivity) and F3 (89.36% specificity and 93.61% sensitivity) gave the best results, being preferentially recognized by immunoglobulin M (IgM) and IgG in sera from patients with acute and chronic toxoplasmosis, respectively. Improved scores of specificity (100%) and sensitivity (100%) were achieved when a secondary antibody against human IgG1 instead of total IgG was employed to measure the reactivity of IgG antibodies with the F3 fraction. To purify tachyzoite antigens recognized by human IgM or IgG antibodies, the F2 or F3 fraction was loaded onto an octyl-Sepharose column and eluted with a propan-1-ol gradient. The main antigen(s) recognized by IgM or IgG eluted in a single peak from the octyl-Sepharose resin loaded with either F2 (30 to 50% propan-1-ol) or F3 (15 to 35% propan-1-ol), respectively. These semipurified fractions gave improved scores when used to detect T. gondii-specific IgM (95.7% specificity and 81.8% sensitivity) or IgG (100% specificity and 93. 75% sensitivity) in an enzyme-linked immunosorbent assay. Further biochemical and immunological analyses of antigens partially purified from F2 and F3 indicate that glycoinositolphospholipids are preferentially recognized by IgM, whereas proteins of approximately 30 to 40 kDa are recognized by IgG, elicited during T. gondii infection in humans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10747125      PMCID: PMC86463     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

Review 1.  The current status of the glycobiology of Toxoplasma gondii: glycosylphosphatidylinositols, N- and O-linked glycans.

Authors:  R T Schwarz; S Tomavo
Journal:  Res Immunol       Date:  1993-01

Review 2.  Toxoplasma gondii: a protozoan for the nineties.

Authors:  K A Joiner; J F Dubremetz
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

Review 3.  Toxoplasmic encephalitis in AIDS patients and experimental models for study of the disease and its treatment.

Authors:  Y Suzuki; J S Remington
Journal:  Res Immunol       Date:  1993-01

4.  Recognition of recombinant Toxoplasma gondii antigens by human sera in an ELISA.

Authors:  A M Tenter; A M Johnson
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

5.  Evidence for glycosyl-phosphatidylinositol anchoring of Toxoplasma gondii major surface antigens.

Authors:  S Tomavo; R T Schwarz; J F Dubremetz
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

6.  Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome.

Authors:  S B Porter; M A Sande
Journal:  N Engl J Med       Date:  1992-12-03       Impact factor: 91.245

7.  A family of glycolipids from Toxoplasma gondii. Identification of candidate glycolipid precursor(s) for Toxoplasma gondii glycosylphosphatidylinositol membrane anchors.

Authors:  S Tomavo; J F Dubremetz; R T Schwarz
Journal:  J Biol Chem       Date:  1992-06-15       Impact factor: 5.157

8.  The alpha- and beta-tubulins of Toxoplasma gondii are encoded by single copy genes containing multiple introns.

Authors:  S D Nagel; J C Boothroyd
Journal:  Mol Biochem Parasitol       Date:  1988-06       Impact factor: 1.759

9.  Western Blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies.

Authors:  S D Sharma; J Mullenax; F G Araujo; H A Erlich; J S Remington
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

10.  Developmental changes in the glycosylated phosphatidylinositols of Leishmania donovani. Characterization of the promastigote and amastigote glycolipids.

Authors:  M J McConville; J M Blackwell
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

View more
  9 in total

1.  Cell wall glycolipids from Corynebacterium pseudotuberculosis strains with different virulences differ in terms of composition and immune recognition.

Authors:  Miriam Flores Rebouças; Dan Loureiro; Thiago Doria Barral; Nubia Seyffert; José Tadeu Raynal; Thiago Jesus Sousa; Henrique Cesar Pereira Figueiredo; Vasco Azevedo; Roberto Meyer; Ricardo Wagner Portela
Journal:  Braz J Microbiol       Date:  2020-07-25       Impact factor: 2.476

2.  Sequential recognition of antigenic markers of Toxoplasma gondii tachyzoite by pooled sera of mice with experimental toxoplasmosis.

Authors:  Fayza Sayed Mohamed Habib; Nehad Mahmoud Ali; Azza Abdel-Salam El-Kadery; Salwa Ahmed Soffar; Mona Gamal Abdel-Razek
Journal:  Parasitol Res       Date:  2010-09-22       Impact factor: 2.289

3.  Immunoglobulin M (IgM)-glycoinositolphospholipid enzyme-linked immunosorbent assay: an immunoenzymatic assay for discrimination between patients with acute toxoplasmosis and those with persistent parasite-specific IgM antibodies.

Authors:  Mónica Giraldo; Ricardo W D Portela; Mirian Snege; Paulo G Leser; Mário E Camargo; José Roberto Mineo; Ricardo T Gazzinelli
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

4.  MyD88-dependent protective immunity elicited by adenovirus 5 expressing the surface antigen 1 from Toxoplasma gondii is mediated by CD8(+) T lymphocytes.

Authors:  Erica A Mendes; Bráulia C Caetano; Marcus L O Penido; Oscar Bruna-Romero; Ricardo T Gazzinelli
Journal:  Vaccine       Date:  2011-05-05       Impact factor: 3.641

5.  Humoral and cellular immune responses to Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas' disease.

Authors:  Vladimir Michailowsky; Keith Luhrs; Manoel Otávio C Rocha; David Fouts; Ricardo T Gazzinelli; Jerry E Manning
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

6.  Unspecific reactivity of IgM directed against the low-molecular-weight antigen of Toxoplasma gondii.

Authors:  A Dao; N Azzouz; C Eloundou Nga; J F Dubremetz; R T Schwarz; B Fortier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-24       Impact factor: 3.267

7.  Toxoplasma-SPECIFIC IgG SUBCLASS ANTIBODY RESPONSE IN CEREBROSPINAL FLUID SAMPLES FROM PATIENTS WITH CEREBRAL TOXOPLASMOSIS.

Authors:  Fernanda S Nascimento; Lisandra A Suzuki; Nilson Branco; Regina M B Franco; Paula D Andrade; Sandra C B Costa; Marcelo N Pedro; Cláudio L Rossi
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Sep-Oct       Impact factor: 1.846

8.  Identification of membrane-associated proteins with pathogenic potential expressed by Corynebacterium pseudotuberculosis grown in animal serum.

Authors:  José Tadeu Raynal; Bruno Lopes Bastos; Priscilla Carolinne Bagano Vilas-Boas; Thiago de Jesus Sousa; Marcos Costa-Silva; Maria da Conceição Aquino de Sá; Ricardo Wagner Portela; Lília Ferreira Moura-Costa; Vasco Azevedo; Roberto Meyer
Journal:  BMC Res Notes       Date:  2018-01-25

9.  Recombinant vaccines against T. gondii: comparison between homologous and heterologous vaccination protocols using two viral vectors expressing SAG1.

Authors:  Érica Araújo Mendes; Flavio G Fonseca; Bárbara M Casério; Janaína P Colina; Ricardo Tostes Gazzinelli; Braulia C Caetano
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.